Bausch 医疗
BHC
6.30
-0.01
-0.16%
Bausch 医疗
US · BHC
#2722 按市值排名
上市于 1970
6.30
-0.01
-0.16%
实时 - 追踪5344个代码 - 心跳于314秒前
· 2026-10-16 19:30
最新新闻
-
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7\u5e02\u573a\u8d44\u8baf · 2026/6/4
-
评级变动
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $6.78\u5e02\u573a\u8d44\u8baf · 2025/7/25
-
评级变动
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7\u5e02\u573a\u8d44\u8baf · 2026/2/21
-
评级变动
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8\u5e02\u573a\u8d44\u8baf · 2026/1/7
-
评级变动
Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)TipRanks · 2026/4/27
-
公司公告
MCOM: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BHC HOLDINGS SDN. BHD.Bursa Malaysia · 2026/6/5
-
评级变动
Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8\u5e02\u573a\u8d44\u8baf · 2025/8/5
-
评级变动
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10\u5e02\u573a\u8d44\u8baf · 2026/2/19
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9\u5e02\u573a\u8d44\u8baf · 2026/4/27
-
评级变动
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 2025/10/30
-
评级变动
BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5\u5e02\u573a\u8d44\u8baf · 2026/2/19
-
评级变动
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating\u5e02\u573a\u8d44\u8baf · 2026/2/19
-
评级变动
Truist Financial Initiates Bausch Health(BHC.US) With Hold Rating\u5e02\u573a\u8d44\u8baf · 2025/7/30
-
评级变动
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8\u5e02\u573a\u8d44\u8baf · 2026/1/24
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9\u5e02\u573a\u8d44\u8baf · 2026/7/31
-
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $7 to $9\u5e02\u573a\u8d44\u8baf · 2026/5/1
-
评级变动
TR | OpenAI - 4o Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $5.81\u5e02\u573a\u8d44\u8baf · 2025/8/11
-
Earnings Call Summary | Bausch Health(BHC.US) Q1 2026 Earnings Conference\u5e02\u573a\u8d44\u8baf · 2026/4/30
-
评级变动
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7\u5e02\u573a\u8d44\u8baf · 2026/2/25
-
评级变动
Analysts Offer Insights on Healthcare Companies: Heart Test Laboratories, Inc. (HSCS) and Bausch Health Companies (BHC)TipRanks · 2025/7/29
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
Bausch 医疗 讨论区 0 条评论